Skip to main content
SpringerLink
Log in

Serum markers of bone formation in parenteral nutrition patients

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Bone gamma-carboxyglutamic acid containing protein (BGP) has been utilized effectively as a serum marker of bone turnover in healthy normals and in individuals with a variety of metabolic bone disorders including postmenopausal osteoporosis and Paget's disease. The utility of this serum marker in other bone disorders, including that associated with the maintenance of patients on long-term parenteral nutrition, still requires definition. Because of our interest in this clinical syndrome and the availability of serum and of bone formation rates (BFR) measured directly from double tetracycline labeling in 11 long-term parenteral nutrition patients, we measured BGP levels in these patients and attempted to correlate this measure with BFR. Serum vitamin D metabolites, immunoreactive parathyroid hormone (PTH), and alkaline phosphatase (alk phos) were also measured. Serum BGP was only weakly and not significantly correlated (r=0.24, p=NS) with bone formation rate for the group as a whole. However, in a subgroup of 10 patients without hyperparathyroidism, there was strong and significant correlation (r=0.81,P<0.01) between BGP and BFR. There was also a strong correlation between bone formation rate and serum 1,25 dihydroxyvitamin D [1,25(OH)2D] levels (r=0.89,P<0.01, n=11). The mechanism of this association could not be established. A correlation of borderline significance was observed between bone formation rate and serum alk phos (r=0.60,P=0.05, n=11). The current data suggest that additional studies may help to more fully define the utility of serum measurements in quantifying bone dynamics in parenteral nutrition patients, and that measures of vitamin D metabolites, BGP, and alk phos may prove useful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klein GL, Targoff CM, Ament ME, Sherrard DJ, Bluestone R, Young JH, Norman AW, Coburn JW (1980) Bone disease associated with total parenteral nutrition. Lancet II:1041–1044

    Article  Google Scholar 

  2. Shike M, Harrison JE, Sturtridge WC, Tam CS, Bobechko PE, Jones G, Murray TM, Jeejeebhoy KN (1980) Metabolic bone disease in patients receiving long-term parenteral nutrition. Ann Int Med 92:343–350

    PubMed  CAS  Google Scholar 

  3. Jeejeebhoy KN, Shike M, Sturtridge WC, Tam CS, Jones G, Murray TM, Harrison JE (1985) TPN bone disease at Toronto. In Coburn JW, Klein GL (eds) Metabolic bone disease in total parenteral nutrition. Urban and Schwarzenberg, Baltimore, Maryland, pp 18–29

    Google Scholar 

  4. Ament ME, Coburn JW, Klein GL (1985) Parenteral nutrition-associated bone disease as encountered in southern California. In Coburn JW, Klein GL (eds) Metabolic bone disease in total parenteral nutrition. Urban and Schwarzenberg, Baltimore, Maryland, pp 32–51

    Google Scholar 

  5. Seligman JV, Basi SS, Deitel M, Bayley TA, Khanna RK (1984) Metabolic bone disease in a patient on long-term total parenteral nutrition: a case report with review of literature. J Parent Ent Nutr 8:722–727

    CAS  Google Scholar 

  6. Shike M, Shils ME, Heller A, Alcock N, Vigorita V, Brockman R, Holick MF, Lane J, Flombaum C (1986) Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. Am J Clin Nutr 44:89–98

    PubMed  CAS  Google Scholar 

  7. Ott SM, Maloney NA, Klein GL, Alfrey AC, Ament ME, Coburn JW, Sherrard DJ (1983) Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Int Med 98:910–914

    PubMed  CAS  Google Scholar 

  8. Shike M, Sturtridge WC, Tam CS, Harrison JE, Jones G, Murray TM, Husdan H, Whitwell C, Wilson DR, Jeejeebhoy KN (1981) A possible role of vitamin D in the genesis of parenteral nutrition-induced metabolic bone disease. Ann Int Med 95:560–568

    PubMed  CAS  Google Scholar 

  9. Tam CS, Jeejeebhoy KN (1985) Bone changes in patients on total parenteral nutrition: follow-up by sequential bone biopsies. In Coburn JW, Klein GL (eds) Metabolic bone disease in total parenteral nutrition. Urban and Schwarzenberg, Baltimore, Maryland, pp 64–72

    Google Scholar 

  10. de Vernejoul MC, Messing B, Modrowski D, Bielakoff J, Buisine A, Miravet L (1985) Multifactorial low bone remodeling bone disease during cyclic total parenteral nutrition. J Clin Endocrinol Metab 60:109–113

    PubMed  Google Scholar 

  11. Lipkin EW, Ott SM, Klein GL (1987) Heterogeneity of bone histology in parenteral nutrition patients. Am J Clin Nutr 46:673–680

    PubMed  CAS  Google Scholar 

  12. Klein GL, Horst RL, Norman AW, Ament ME, Slatopolsky E, Coburn JW (1981) Reduced serum levels of 1,25-dihydroxyvitamin D during long-term total parenteral nutrition. Ann Int Med 94:638–643

    PubMed  CAS  Google Scholar 

  13. Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:878–883

    PubMed  CAS  Google Scholar 

  14. Cole DEC, Carpenter TO, Gundberg CM (1985) Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatrics 106:770–776

    Article  CAS  Google Scholar 

  15. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Edouard C, Meunier PJ (1986) Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. J Clin Invest 77:985–991

    PubMed  CAS  Google Scholar 

  16. Stepan JJ, Presl J, Brovlik P, Pacousky J (1987) Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin End Met 64:1079–1082

    CAS  Google Scholar 

  17. Deftos LJ, Parthemore JG, Price PA (1982) Changes in plasma BGP during treatment of bone disease. Calcif Tissue Int 34:121–124

    Article  PubMed  CAS  Google Scholar 

  18. Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy M-C, Meunier PJ (1986) Serum bone Glaprotein in renal osteodystrophy: comparison with bone histomorphometry. J Clin Endocrinol Metab 63:892–897

    PubMed  CAS  Google Scholar 

  19. Delmas PD, Wahner HW, Mann KG, Riggs BL (1983) Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone GLA-protein. J Lab Clin Med 102:470–476

    PubMed  CAS  Google Scholar 

  20. Brown JP, Malaval L, Chapuy MC, Delmas PD, Edouard C, Meunier PJ (1984) Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1:1091–1093

    Article  PubMed  CAS  Google Scholar 

  21. Podenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C (1987) Bone turnover in spinal osteoporosis. J Bone Min Res 2:497–503

    CAS  Google Scholar 

  22. Farley JR, Baylink DJ (1986) Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 35:563–571

    Article  PubMed  CAS  Google Scholar 

  23. Price P (1983) Osteocalcin. In: Peck WA (ed) Bone and mineral research, Ann I. Excerpta Medica, Princeton, New Jersey, pp 157–190

    Google Scholar 

  24. Lipkin EW, Ott SM, Chesnut CH III, Chait A (1988) Mineral loss in the parenteral nutrition patients. Am J Clin Nutr 47:515–523

    PubMed  CAS  Google Scholar 

  25. Fleming CR, McGill DB, Berkner S (1977) Home parenteral nutrition as primary therapy in patients with extensive Crohn's disease of the small bowel and malnutrition. Gastroenterology 73:1077–1081

    PubMed  CAS  Google Scholar 

  26. Strobel CT, Byrne WJ, Ament ME (1979) Home parenteral nutrition in children with Crohn's disease: an effective management alternative. Gastroenterology 77:272–279

    PubMed  CAS  Google Scholar 

  27. Jeliffe DB (1966) Assessment of nutritional status of the community. World Health Organization, Geneva

    Google Scholar 

  28. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Min Res 2:595–610

    Article  CAS  Google Scholar 

  29. Legendre GR, Alfrey AC (1976) Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption of a chelate. Clin Chem 22:53–56

    PubMed  CAS  Google Scholar 

  30. Orwoll E, Koppel A, Opsahl W, Roberts L, Endres D, McClung M (1985) Hypochlorite radioiodination of parathyroid peptides [h PTH1–34, (TYR43) h. PTH44–68]. J Lab Clin Med 105:247–253

    PubMed  CAS  Google Scholar 

  31. Tofaletti J, Nissenson R, Endres D, McGarry E, Mogollon G (1985) Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapharesis. J Clin End Met 60:874–879

    Google Scholar 

  32. Ellis C, Dixon K (1977) Sequential-saturation-type assay for serum 25-hydroxy vitamin D. Clin Chem 23:855–862

    PubMed  CAS  Google Scholar 

  33. Reinhardt TL, Horst RL, Orf JW, Hollis BW (1984) A microassay for 1,25-dihydroxy vitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58:91–98

    PubMed  CAS  Google Scholar 

  34. Christiansen C, Nilas L, Riis BJ, Rødbro P, Deftos L (1985) Uncoupling of bone formation and resorption by combined oestrogen and progestogen therapy in postmenopausal osteoporosis. Lancet II:800–801

    Article  Google Scholar 

  35. Snedecor GW, Cochran WG (1980) Statistical methods, 7th ed. Iowa State University Press, Ames, Iowa

    Google Scholar 

  36. Alfrey AC (1984) Aluminum intoxication. N Engl J Med 310:1113–1114

    Article  PubMed  CAS  Google Scholar 

  37. Sherrard DJ (1986) Renal osteodystrophy. Semin Nephrol 6:56–67

    PubMed  CAS  Google Scholar 

  38. Karton MA, Rettmer RA, Lipkin EW, Ott SM, Chait A (1989) D-lactate and metabolic bone disease in patients on long-term parenteral nutrition. J Parent Ent Nutr 13:132–135

    Article  CAS  Google Scholar 

  39. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S (1989) Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213–221

    PubMed  CAS  Google Scholar 

  40. Bouillion R, Auwerx J, Dekeyser L, Fevery J, Lissens W, DeMoor P (1984) Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 59:86–89

    Google Scholar 

  41. Klein GL, Endres DB, Colonna JD II, Berquist WE, Goldstein LI, Busuttil RW, Deftos LJ (1989) Absence of hyperparathyroidism in severe liver disease. Calcif Tissue Int 44:330–334

    PubMed  CAS  Google Scholar 

  42. Vargas JH, Klein GL, Ament ME, Ott SM, Sherrard DJ, Horst RL, Berquist WE, Alfrey AC, Slatapolsky E, Coburn JW (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr 48:1070–1078

    PubMed  CAS  Google Scholar 

  43. Andress D, Endres DB, Maloney NA, Kopp JA, Coburn JW, Sherrard DJ (1986) Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 63:1163–1169

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Washington, Seattle, Washington, USA

    Edward W. Lipkin M.D., Ph.D. & Susan M. Ott

  2. Department of Medicine, University of California, La Jolla, California, USA

    Leonard J. Deftos

  3. Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA

    Gordon L. Klein

  4. Department of Medicine, San Diego VA Medical Center, La Jolla, California, USA

    Leonard J. Deftos

Authors
  1. Edward W. Lipkin M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan M. Ott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon L. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leonard J. Deftos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipkin, E.W., Ott, S.M., Klein, G.L. et al. Serum markers of bone formation in parenteral nutrition patients. Calcif Tissue Int 47, 75–81 (1990). https://doi.org/10.1007/BF02555990

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02555990

Key words

Search

Navigation